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Abstract 
 
Accurate detection of cognitive impairment is a fundamental part of neuropsychological 
assessment, and assessment of memory decline is particularly important because it is a common 
reason for referral. Discrepancy analysis is a method of detecting memory decline which 
involves comparing the patient’s present test scores with an expected level of performance. The 
patient’s expected level of performance on memory tests frequently is their level of performance 
on intelligence measures. However, there are differing positions in the literature regarding the 
relationship between intelligence and memory and accurate understanding of this relationship is 
critical to the discrepancy analysis approach. This study examines the relationship between four 
measures of memory and four estimates of intelligence to evaluate the relationship between these 
constructs and determine if comparison of intelligence and memory test scores is a valid method 
of identifying memory impairment. The sample (N = 167) included patients referred to a 
university doctoral clinical psychology training and research center for neuropsychological 
assessment. Results indicate memory scores increase with intelligence scores, though they are 
not linear correlates across all levels of intelligence. In particular, memory tends to be lower than 
intellectual ability in individuals with above average intelligence. The clinical implications of 
these findings are discussed and with recommendations for clinical practice.  
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1 
The Association between Measures of Intelligence and Memory 
In a Clinical Sample 
 One of the fundamental assumptions of neuropsychological assessment is that we can 
objectively measure cognitive abilities from a defined standard, thus detecting deficits and 
decline, as well as strengths. The identification and measurement of cognitive deficits is a 
defining characteristic of clinical neuropsychology, as it is through cognitive and behavioral 
deficiencies and dysfunctional alterations that brain disorders often are manifest (Lezak, 
Howieson, & Loring, 2004). The assessment of cognitive impairment is important because it 
accompanies nearly all brain dysfunction and is a defining diagnostic feature of many 
neurological disorders (Lezak et al., 2004).  
 In clinical neuropsychology, there are various approaches to identifying test scores that 
represent cognitive impairment. One method utilizes cut-off scores that are meant to distinguish 
abnormal test scores from those in the normal population. This technique is typically used in 
brief cognitive screening measures, such as the Mini Mental Status Examination (MMSE; 
Folstein, Folstein & McHugh, 1975). These tests contain items with a relatively low ceiling that 
most adults can easily complete and therefore, more than one or two errors is suggestive of 
cognitive impairment. Another approach involves direct comparison of a patient’s test score 
against the standardized normative group used in the development of the test measure. The 
patient’s raw data typically is compared with the performance of other individuals of similar age 
and then converted into a standardized score, such as a T-score or percentile. The patient’s 
converted score indicates if the patient has performed equal to, above, or below the normative 
standard called the average score (Lezak at al., 2004). In this method, scores below a certain 
point (e.g., more than 1.5 standard deviations below the average) are considered to represent a 
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level of functioning that is outside of normal limits, thus likely indicating cognitive impairment. 
Yet another method for determining impairment involves comparing the patient’s test score on 
some tests against their scores on other tests, using an individual comparison standard 
(Crawford, Johnson, Mychalkiw, & Moore, 1997). The assumption of this approach, referred to 
as discrepancy analysis, is that it allows the examiner to appreciate areas of decline, while also 
noting areas of preserved functioning against a patient’s own baseline of relatively stable 
cognitive functions. Notably, test scores may be only slightly outside normal limits when 
compared to the normative group, but for the individual they may represent deficits when 
compared to that individual’s overall abilities. The strengths and weaknesses of each of these 
approaches will be discussed in further detail in the literature review section below.  
 Another important element of neuropsychological evaluation is accurate identification of 
memory impairment. Alterations in memory functioning are often a primary reason individuals 
are referred for neuropsychological examination and, as such, it is imperative neuropsychologists 
are prepared to accurately assess memory dysfunction. While normative comparisons can be 
useful for providing a description of a patient’s memory functioning in terms of population 
norms, they may not be sensitive to decline in memory functions for some patients, especially 
those with above average intellectual ability (Lezak et al., 2004). Based on this reasoning, Lezak 
et al. contend that when examining patients for cognitive decline, “an individual comparison 
approach is the only meaningful method for assessing deficit” (2004, p. 90).  Discrepancy 
analysis is an integral element of this individual comparison approach. In discrepancy analysis, 
IQ scores often are used to establish a baseline by which to compare memory scores and to 
predict the expected level of memory performance for an individual (although Lezak does not 
favor the use of IQ scores). To the extent memory scores are substantially below IQ scores, it is 
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taken as an indication of memory impairment. However, in order to reliably identify when an IQ-
memory test score discrepancy is significant, understanding the relationship between IQ scores 
and memory test performance is critical to this approach.  
 There has long been debate in the literature regarding how to accurately define memory 
impairment using discrepancy analysis. Some believe that memory is a uniquely separate 
construct from intelligence (Dodrill, 1997; Wilding, Valentine, Marshall, & Cook, 1999; 
Larrabee, 2000). As such, those with superior IQs are not necessarily expected to have memory 
abilities within the same range, and a less than superior score on memory measures should not be 
considered a deficit. Others disagree and point to evidence suggesting that those with higher IQs 
also have higher cognitive abilities overall, including memory (Reitan, 1985; Waldmann, 
Dickson, & Kazelskis, 1990; Bell & Roper, 1998; Tremont, Hoffman, Scott, & Adams, 1998). 
Consequently, for a highly intelligent individual, a memory test score in the average range may 
represent a deficit or decline, while a low-average score from a patient with low-average intellect 
may not reflect a memory deficit at all (Crawford et al., 1997). It becomes apparent that it is 
essential to the field of neuropsychology to better understand the relationship between memory 
and intelligence if discrepancy analysis is to be used as a basis for measuring deficits. 
 In the next section, review of literature related to methods of evaluating cognitive 
impairment will be discussed, as will the role of discrepancy analysis in determining memory 
deficit. The relationship between IQ and neuropsychological test scores will be reviewed, with 
specific emphasis on the association of intelligence and memory.  
 
 
 
 
 
 
 
 
4 
Review of Literature 
 
 Discrepancy analysis is one approach used in neuropsychological assessment to identify 
memory impairment, but it is not the only one.  In order to better understand the rationale for 
discrepancy analysis, the focus of this study, various approaches to identifying impairment on 
neuropsychological tests are reviewed. 
Approaches to Identifying Neuropsychological Impairment 
 Cut-off scores. On a continuum of test scores, the score that separates “normal” from 
“abnormal” is called the cutting score and delineates the cut-off point (Lezak et al., 2004). The 
purpose of such a score is to distinguish the presence or absence of impairment, indicating those 
above the cut-off score are unimpaired while those falling below have scores representing 
impairment. Many cognitive screening measures utilize cut-off scores, including the MMSE 
(Folstein et al., 1975), the Saint Louis University Mental Status Examination (SLUMS; Tariq, 
Tumosa, Chibnall, Perry & Morley, 2006), and the Dementia Rating Scale (DRS; Mattis, 1988). 
For the purpose of identifying impaired patients, these tests are generally more accurate than 
chance alone (Lezak et al., 2004). However, there is potential for misdiagnosing both “normal” 
and impaired patients, depending on where the cut-off is set. Higher cut-off scores are more 
likely to identify those with impaired cognition (higher sensitivity), but also more likely to 
falsely identify those who do not have cognitive problems (lower specificity; Brooks, Strauss, 
Sherman, Iverson, & Slick, 2009). Conversely, lower cut-off scores will more likely misidentify 
impaired patients as “normal”. According to Lezak et al. (2004), “Only rarely does the cutting 
score provide a distinct separation between two populations, and then only for tests that are so 
simple that no nonretarded, intact individual could fail (p. 152).” Since using cutoff scores can 
often lead to misdiagnosis, this method is generally reserved for brief screening measures that 
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can be used to determine if further neuropsychological testing in indicated. While these measures 
may be effective in identifying the presence of brain disorders, they should never be used to rule 
out brain dysfunction (Lezak et al., 2004). Thus, the clinical utility of measures utilizing cut-off 
scores is limited.  
 Normative Comparisons. In order to assess neuropsychological constructs, the skill 
being measured must be quantified and represented in numerical scores (Mitrushina, Boone, & 
D’Elia, 1999). Interpretation of raw scores requires that they be compared to the performance of 
a group of individuals on the same test. This normative sample is assumed to be representative of 
the population from which it is drawn (Mitrushina, Boone, & D’Elia, 1999), and is ideally 
composed of individuals demographically similar to the patient. Raw scores are transformed into 
standardized scores which represent the ranking of the individual’s performance in comparison 
to the normative group. Many neuropsychological tests have a normal distribution in which the 
majority of individuals from the standardization group score within 1± standard deviation (SD) 
from the mean. As scores fall further from the mean, they become increasingly less frequent and 
thus, clinically meaningful.  
 Currently, there is no universal consensus regarding the extent of deviation from the 
mean that defines cognitive impairment. Similar to problems setting an appropriate cut-off score, 
setting a normatively based impairment criteria can over- or under-identify individuals as 
cognitively impaired. For example, if using a criterion of 1 SD below the mean, there is a high 
chance of judging too many intact individuals as impaired, since nearly 15% of such individuals 
score within this range (Lezak et al., 2004). Conversely, if the criterion is set at 2 SD below the 
mean, there is increased chance of classifying impaired individuals as intact, which may have 
dire consequences if this results in a disorder going undiagnosed.  Many clinicians have 
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addressed these concerns by using graduated impairment criteria, wherein performances 1 SD 
below represent possible impairment, performances between 1 and 2 SD suggest probable 
impairment, and scores 2 SD below the mean are clear evidence of impairment (Lezak et al., 
2004). It is also important to consider the pattern of impaired scores to determine if there is a 
trend or just a few isolated outliers. In the latter condition, one must recognize there is a 
significant amount of intraindividual variability in the cognitive abilities of normal people, 
including the presence of low scores (Brooks et al., 2009). Therefore, careful evaluation of the 
pattern of test scores is essential.  
 Another concern using normative comparisons that is pertinent to the present study 
relates to how changes in functioning are measured. While normative data allows us to examine 
the patient’s performance as compared to similar individuals, it offers no information regarding 
how the patient’s performance may have changed over time. That is, there is no measurement of 
cognitive decline. Lezak et al. (2004) explain the dilemma well: 
 Concern has been raised that using a criterion for decision making that represents a  
 deviation from the mean of the normative sample rather than change from  premorbid 
 level of functioning is likely to result in missing significant changes in very high 
 functioning individuals while suggesting that low functioning individuals have acquired 
 impairments they do not have (p. 148). 
Furthermore, Feinberg and Farrah (2003) call the practice of using population means as the sole 
comparison standard “not only inappropriate but [potentially] grossly misleading, since one  
quarter of the population performs at levels above the average range and one-quarter fall below it 
(p. 36)”. 
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Given these concerns with both cut-off scores and normative comparison, many 
clinicians employ an individual comparison technique to attempt to measure areas of decline 
from the patient’s own baseline of cognitive abilities. Evaluation of this approach will be 
described next.  
 Discrepancy Analysis. Lezak et al. (2004) state, “Individual comparison standards are 
called for whenever a psychological trait or function that is normally distributed in the intact 
adult population is evaluated for change” (p. 90). It is only by examining prior behavior or 
functioning that we can determine if a person has experienced cognitive decline. Frequently, 
neuropsychologists are at a disadvantage because historical data for a patient is not available. In 
these situations, the clinician must do his or her best to estimate the patient’s prior abilities, also 
known as their premorbid level of functioning.  
 Often, an intelligence estimate is used as a global measure of premorbid functioning. 
There are several ways to estimate premorbid intelligence in neuropsychology, such as using 
measures of reading ability [e.g., the North American Adult Reading Test (NAART); Blair & 
Spreen, 1989], demographic data (e.g., the Barona Index; Barona, Reynolds, & Chastain, 1984) 
or composite scores [e.g., the Wechsler Adult Intelligence Scales (WAIS); Wechsler, 1955, 
1981, 1997, 2008]. Composite scores, Full Scale IQ (FSIQ) in particular, have historically been 
the preferred method of obtaining an overall estimate of an individual’s abilities (in depth review 
of IQ scores will be presented later in this paper). Using the IQ as the premorbid estimate by 
which to compare other scores, scores falling more than 1 SD below this baseline level are 
considered deficits. As referenced in the Lezak et al. (2004, p.148) quote above, individual 
discrepancy analysis can be especially important when assessing a patient with premorbid 
abilities in the above or below average ranges. For example, consider a patient with superior 
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premorbid abilities who scores in the average range on a neuropsychological test. Using standard 
normative data, this score is well within normal limits. However, using discrepancy analysis, the 
score is substantially below the individual’s other scores thus would be considered to possibly 
represent a decline for this patient. For a patient with low average to borderline premorbid 
abilities, a score falling 1.5 SD below the normative group is notably below average.  In this 
case, discrepancy analysis would identify the score as being at the expected level for the patient 
even though it was normatively outside the average range. Thus, the potential value of using 
individual comparison methods in neuropsychological assessment becomes apparent. 
 Discrepancy analysis has gained increased attention in the assessment of memory decline. 
In particular, the Wechsler IQ and Memory scales have routinely been compared, dating back as 
early as 1945 when Wechsler adjusted the Memory Quotient (MQ) to make it comparable to Full 
Scale IQ (FSIQ; Prifitera & Barley, 1985). By utilizing similar scales, and more recently the 
same normative groups (WAIS-III/WMS-III; Wechsler, 1997a, 1997b), direct comparison of 
scores was facilitated. Clinical comparison of measures of memory and IQ is based on the 
assumption that memory scores appreciably lower than intelligence scores may be reflective of 
memory impairment (Moses, Pritchard, & Adams, 1997; Lange & Chelune, 2006). However, as 
noted for other methods of identifying impairment, what constitutes a significant discrepancy 
between measures is not well-defined. To aid in this process, base rate data are provided in the 
WAIS-III/WMS-III Technical Manual (The Psychological Corporation, 1997) and discrepancy 
scores can be easily calculated using scoring software (the WAIS-III/WMS-III/WIAT-II Scoring 
Assistant; The Psychological Corporation, 2001). A limitation of the data in the WMS-III 
technical manual is that predicted memory performance is given only for Index scores. Often it is 
not necessary, or even desirable, to administer all the subtests required to obtain these Index 
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scores. Furthermore, Index scores combine scores across differing tasks (e.g., memory for word 
lists and memory for narratives) in which performance may vary considerably and thus cloud 
rather than clarify assessment of the patient’s memory ability ( Lezak et al. 2004). Presently, 
there is little research evaluating the relationship between IQ and individual memory test scores 
and this information has important clinical application in discrepancy analysis.   
 The potential utility of discrepancy analysis is in large part determined by the accuracy of 
knowledge about the nature of the relationship between IQ and neuropsychological measures. In 
particular, if the relationship is not linear, how can IQ scores be used as a basis of discrepancy 
analysis? Dodrill (1997), for one, asserts the assumption of linearity between IQ and 
neuropsychological test scores is a myth of neuropsychology. He acknowledges a fairly strong 
relationship between IQ and neuropsychological test performance in the below average IQ 
ranges, but notes the strength of this relationship decreases when IQ reaches average or higher. 
Various arguments have been presented against Dodrill’s claim (Bell and Roper, 1998; Tremont 
et al., 1998), and there remains a debate in the literature regarding the relationship between 
intelligence and neuropsychological test performance.  
The next section presents a review of the literature evaluating the relationship between IQ 
and neuropsychological test performance, with specific emphasis on the relationship between IQ 
and memory measures.  
The Relationship between IQ and Neuropsychological Test Performance 
 The relationship between measures of intelligence and neuropsychological functioning 
has long been debated in literature. Some neuropsychologists view general cognitive functions as 
a separate construct from intelligence, while others believe they are inherently related. 
Unfortunately, no consensus has been reached and the debate continues in an attempt to gain a 
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more comprehensive understanding of these two constructs (e.g., Dodrill, 1997; Bell & Roper, 
1997; Tremont et al., 1997; Williams, 1997; Hawkins, 1998; Dodrill, 1999; Larrabee, 2000; 
Hawkins & Tulsky, 2001). 
 An impetus for this debate began with Carl Dodrill’s Presidential Address for Division 40 
of the American Psychological Association (APA; 1995) in which he presented several “myths 
of neuropsychology” in an attempt to debunk erroneous beliefs that limit progress in the field 
(Dodrill, 1997). One myth referred to the belief that “above average performances on 
neuropsychological tests are expected when intellectual abilities are above average” (Dodrill, 
1997). As such, a high correlation between intelligence scores and other neuropsychological 
measures is assumed and if neuropsychological scores are below intelligence scores they should 
be evaluated as potential deficits. However, Dodrill claims this assumption is a mistake, as 
intelligence often surpasses memory and other neuropsychological functions.   
 To evaluate this relationship, Dodrill studied 181 normal controls by assessing WAIS-R 
FSIQ (Wechsler, 1981), Halstead Impairment Index (HII) of the Halstead-Reitan 
Neuropsychological Test Battery (Halstead, 1947; Reitan, 1955c ), and Dodrill Discriminability 
Index (DDI) of the Neuropsychological Battery for Epilepsy (Dodrill, 1978). Results revealed a 
fairly high positive correlation between intelligence and the impairment indices up through IQ 
levels of 90 to 95; however, for IQ scores above 100 there was little improvement on 
neuropsychological measures (Dodrill, 1978). Three explanations were given to elucidate this 
pattern. First, performance on neuropsychological measures is not normally distributed because 
they are meant to differentiate abnormal brain functioning (a rarity) from normal brain 
functioning; IQ, on the other hand, is normally distributed. Second, regression to the mean 
effects result in patients with higher IQ scores having lower scores on other measures and vice 
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versa; Larrabee (2000) echoes this concern, noting that regression effects are most pronounced 
for extreme scores. Third, some tests are not sensitive to intelligence and would not be expected 
to improve with increases in intelligence (e.g., motor tests). Taken together, Dodrill (1997) 
concludes: 
 People who are above average in intelligence perform no differently on 
 neuropsychological tests than people of average intelligence. Thus, it is not appropriate to 
 conclude that a particular person must have sustained brain damage because there is 
 evidence that intelligence was above average premorbidly while scores on 
 neuropsychological tests are now “only average”. (p.13) 
 Bell and Roper (1998) and Tremont et al. (1998) published rebuttals to Dodrill’s (1997) 
claim. Bell and Roper (1998) provided contrary evidence from IQ-stratified normative studies 
that suggested above-average intelligence is associated with above-average neuropsychological 
abilities. For example, using IQ stratified data from the California Verbal Learning Test (CVLT; 
Delis, Kramer, Kaplan, & Ober, 1987), a raw score of 49 for the five learning trials resulted in 
very different scores for a patient in the average intelligence range (an average performance) 
versus a patient in the superior range (an impaired performance; Wiens, Tindall, and Crossen, 
1994, as cited in Bell and Roper, 1998). The authors conclude that Dodrill’s claim is itself a 
myth in the making and posit a more accurate claim is that “people who are above average in 
intelligence are likely to perform within the above average range on some, not necessarily all, 
neuropsychological tests (Bell and Roper, 1998, p.242).” Tremont et al. (1998) re-evaluated 
Dodrill’s (1997) data by stratifying data into below average, average, and above average groups 
and concluded that individuals with above average IQs performed significantly better on 
neuropsychological measures than those in the average or below average groups. Tremont et al. 
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(1998) also noted that IQ scores are partial reflections of an individual’s age and education, but 
found IQ contributed statistically to the variance accounted for in neuropsychological scores, 
even after controlling for these variables (p.564). As such, they recommended clinicians adjust 
their expectations for neuropsychological test performance based upon an individual’s IQ level. 
 In 1999 Dodrill clarified his statement and addressed criticisms while standing by his 
position. He noted the statement of the “myth” was meant to bring attention to the fact that 
neuropsychological test performance correlates highly with intelligence when IQ is below 
average; however, when this relationship decreases significantly in above average IQs. While 
Dodrill acknowledged that neuropsychological test scores do generally increase with intelligence 
(as noted in Bell & Roper, 1998; Tremont et al., 1998), his concern is that there are only slight 
improvements between the average and above average groups. Therefore, he modified his myth 
to state “Just as below average performances on neuropsychological tests are found when 
intelligence is below average, to that same degree above-average performances on 
neuropsychological tests are expected when intellectual abilities are above average” (p. 568).  
 IQ and memory. There is considerable literature devoted specifically to understanding 
the association of IQ and memory test performance. Following Dodrill’s lead, Williams (1997) 
further acknowledged that there is an underlying assumption among neuropsychologists that IQ 
and memory scores should be highly correlated among normal, unimpaired subjects. Williams 
found 25% of the normal population has a standard score difference of at least 18 points between 
IQ and memory as assessed with the WMS-R and the Memory Assessment Scales (MAS; 
Williams, 1992) index scores. This suggests that just as patients can have substantial VIQ-PIQ 
discrepancies on IQ tests, they can also have IQ-Memory discrepancies (Williams, 1997). These 
findings raise concerns about using premorbid estimates of intelligence as the baseline to infer 
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memory dysfunction. Because significant IQ-memory test differences are common, the author 
argues an estimate of premorbid memory would be more appropriate for use in discrepancy 
analysis. Unfortunately, it is difficult to predict premorbid memory functioning and no such 
measures are currently available. Williams cautions that in order to infer impairment using IQ-
Memory discrepancies, patients must score within the impaired range on memory tests in 
addition to manifesting large differences between intellectual estimates and current scores. 
 IQ-Memory discrepancy analysis became increasingly common with the development 
and conorming of the WAIS-III and the Wechsler Memory Scale – Third Edition (WMS-III; 
Wechsler, 1997b). Hawkins (1998) examined the Index scores of the clinical samples provided 
in the WAIS-III/WMS-III technical manual, including patients with mild Alzheimer’s disease, 
Huntington’s disease, Parkinson’s disease, traumatic brain injury, chronic alcohol abuse, 
Korsakoff’s syndrome, schizophrenia, multiple sclerosis, left lobectomy and right lobectomy 
(Psychological Corporation, 1997). Results revealed FSIQ scores exceeded Memory Indices in 
every principle sample from 1 to 35 points. While the difference between IQ and memory scores 
was large in some groups with severe memory impairment (i.e., Alzheimer’s and Korsokoff’s 
diseases), in the other clinical groups, the discrepancy was less than 10 points. Given that 
approximately 25% of the standardization sample has IQ-Memory Index discrepancies of at least 
10 points (Hawkins, 1998), it is difficult to infer that this difference among clinical groups is 
representative of memory impairment.  Hawkins (1998) further cautions that the IQ-Memory 
comparison is complicated by only modest correlations between memory and IQ measures; .60 
in the standardization sample (Psychological Corporation, 1997).  
 Further, analysis of discrepancy directionality in the WMS-III standardization sample by 
Hawkins and Tulsky (2001) revealed a nearly even split between cases exhibiting superiority of 
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IQ and those exhibiting superiority of General Memory Index (GMI) within the average range 
(90-109). Of those with FSIQ 80 and below, FSIQ exceeded GMI in 16.1% of cases, whereas 
FSIQ exceeded GMI in 86.6% of cases with FSIQ 120 and above. Caution must be used when 
interpreting IQ-Memory discrepancies, as Hawkins and Tulsky (2001) explicate: 
 With lower IQ subjects there is a heightened false negative risk: IQ-GMI discrepancies 
 are likely to be interpreted as not providing evidence of decline, when in fact memory 
 decline has occurred. A higher GMI (than FSIQ) is the norm; therefore, counterintuitive 
 though it seems, a small discrepancy in favor of IQ may speak to a relative weakness in 
 memory. Conversely, given that IQ increasingly outstrips GMI as FSIQ rises above the 
 average range, so too does the risk for false positive decisions. (p. 877-878) 
 
The WAIS-III/WMS-III technical manual (Psychological Corporation, 1997) provides 
estimates of WMS-III Index scores predicted from WAIS-III FSIQ scores. Estimates provided in 
the table indicate that memory index scores are expected to be greater than IQ up to FSIQ of 101; 
beginning at FSIQ 102, IQ is anticipated to be greater than memory scores (Table B.1. in the 
WAIS-III/WMS-III technical manual). This suggests that IQ and memory are not linear 
correlates and it is important to understand this relationship when using IQ-Memory discrepancy 
analysis.  
Wilding, et al. (1999) examined the relation of IQ to two factors of the WMS-R 
(Wechsler, 1987): a general memory factor and an attention-concentration factor. IQ loaded 
primarily with the attention-concentration factor, suggesting that major aspects of memory are 
independent of IQ. Further evidence of this independence comes from a study of early 
hippocampal damage by Varga-Khadem and Gadian (1997). These authors examined three cases 
of early childhood bilateral hippocampal pathology resulting in global anterograde amnesia. 
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Rather than having global intellectual impairment due to disrupted cognitive development, all 
three patients had generally intact cognition, with impairment limited to loss of episodic 
memory. Semantic memory required for acquiring factual knowledge was intact as well, 
suggesting that “the basic sensory memory functions of the perirhinal and entorhinal cortices 
may be largely sufficient to support the formation of context-free semantic memories but not of 
the context-rich episodic memories, which require additional processing by the hippocampal 
circuit” (p.380). In other words, intelligence was preserved through the intact surrounding 
cortices and memory alone was disrupted.  However, interpretation of these findings may not be 
this straightforward because these subjects sustained brain damage in childhood, raising the 
possibility that their brains – and the relationship between memory and intelligence – may have 
developed differently.  Thus, they may not be representative of normal functioning in either area. 
In summary, some evidence suggests that IQ-Memory discrepancies may have a 
complicated clinical application due to differences in IQ-memory discrepancy distributions 
among the general population, large discrepancies in the normal population, and only moderate 
correlations between the constructs. Evidence of the contrary will be presented next. 
 Rapport, Axelrod, Thiesen, Brines, Kalechstein, and Ricker (1997) explored the 
relationship between IQ and verbal memory in normals using the WMS-R (Wechsler, 1987) and 
the CVLT (Delis et al., 1987). Results revealed the low average IQ group performed 
significantly more poorly on the WMS-R General Memory and Delayed Recall indices, as well 
as on the CVLT Total Words and Discriminability indices, in comparison to those in the average 
and high average groups where mean scores were statistically equivalent. Also of interest, the 
average and high average groups had equivalent learning slopes that were steeper than the low 
average group, suggesting greater learning across trials. The lack of significant difference 
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between the average and high average groups is consistent with previously reviewed findings 
that indicate neuropsychological test performance does not increase significantly above the 
average range. They concluded their findings supported the notion of a meaningful relationship 
between measures of intelligence and memory and noted that VIQ alone accounted for up to 
37% of the variability in learning and memory test scores (Rapport et al., 1997). In addition, they 
postulated that memory tests are sensitive not only to memory demands but a variety of other 
factors including problem-solving strategies, clustering techniques (e.g., semantic or serial 
organization), and other cognitive organizational skills that may overlap with elements of 
intelligence (Rapport et al., 1997).  
 Much of the research relating to FSIQ and memory test performance indicates there is a 
greater correspondence between the two in the below average IQ range, while greater 
discrepancies occur with IQs in the above average range. However, some researchers maintain 
that FSIQ is not the best indicator of an individual’s overall cognitive functioning and thus not 
the best basis for discrepancy analysis. An alternative approach to measuring intelligence and 
performing discrepancy analysis is presented next.  
GAI and memory. Historically, FSIQ has been used as the measure of baseline 
functioning by which to compare memory scores. FSIQ is derived from subtests that measure a 
variety of cognitive abilities that have both high and low loadings on a general intelligence 
factor, or g, which is thought to be the general mental ability best defining intelligence (first 
described by Spearman, 1904).  Subtests that have a higher loading on g are thought to be more 
stable measures of intelligence than those with low factor loadings like Digit Span, Arithmetic, 
Coding and Symbol Search (Kaufman & Lichtenberger, 1999).  These subtests with low g 
loadings are posited to be more susceptible to the influence of brain injury than subtests with 
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high loadings on g, thus making FSIQ susceptible to brain injury (Kaufman & Lichtenberger, 
1999).  For example, Reitan (1985) found that control subjects had higher IQ scores than a group 
of TBI patients.  The variability in FSIQ subtest factor loadings on g raises the question of 
whether Reitan’s subjects experienced reduced global cognitive capacity or had specific deficits 
on certain subtests that resulted in decreased composite IQ scores. The concern that FSIQ scores 
are vulnerable to brain injury and therefore often may not be a valid basis for discrepancy 
analysis has been noted by others (Bornstein, Chelune, and Prifitera, 1989; Hawkins, 1998). 
Thus, in an attempt to measure intellectual abilities more representative of premorbid 
intelligence, the General Ability Index (GAI) was created, initially for use with the Wechsler 
Intelligence Scale for Children – Third Edition (WISC-III; Wechsler, 1991). GAI is based on the 
sum of scaled scores of subtests that make up the Verbal Comprehension Index (VCI) and 
Perceptual Organization Index (POI; Tulsky et al., 2001). VCI and POI are composed of subtests 
with higher g loadings than the Working Memory Index (WMI) and Processing Speed Index 
(PSI; Kaufman & Lichtenberger, 1999). Two of the three POI subtests and all VCI subtests have 
g factor loadings of .70 or higher; in contrast, only one of two subtests in PSI and one of three 
WMI subtests have a high g loading (Kaufman & Lichtenberger, 1999). Thus, by eliminating 
WMI and PSI the remaining VCI and POI are hypothesized to be "purer" measures of verbal and 
nonverbal intellectual abilities, respectively (Glass, Bartels, & Ryan, 2009). Moreover, the 
developers of GAI have argued this score is a better indicator of g than FSIQ because it 
eliminates subtests that load more heavily on other cognitive abilities (i.e., working memory and 
processing speed; Prifitera, Weiss, & Soklofske, 1998).  
Tulsky et al. (2001) used the standardization data from the WAIS-III to develop a GAI 
scale with normative tables for use in assessment of adult intelligence. In addition to the 
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arguments above, the authors posit GAI is more practical and time-efficient because it does not 
require administration of all 13 subtests needed to calculate the FSIQ (Tulsky et al., 2001). If one 
wants to obtain all four WAIS-III indices and calculate a global composite score, GAI is 
preferable because it only requires administration of 11 subtests (omitting the lengthy 
Comprehension and Picture Arrangement subtests; Tulsky et al., 2001). However, it is important 
to note the GAI is not a “short form” of the FSIQ; rather it is an alternative estimate of general 
ability. In Tulsky et al.’s (2001) study, there was a .96 correlation between FSIQ and GAI, 
indicating a strong relationship between these ability scores. The distribution of GAI scores by 
different ability classifications (e.g., low average, average, above average, etc.) was also found to 
generally follow a theoretical normative curve, suggesting a similar distribution as FSIQ scores. 
The authors do not claim GAI is a superior estimate of intelligence compared to FSIQ; rather, 
they offer this as an alternative method of estimating ability without the influence of variables 
that are less related to the g factor and more susceptible to brain dysfunction. While FSIQ and 
GAI are highly correlated in normals, the review that follows indicates that the GAI is less 
vulnerable to the effects of brain injury than the FSIQ, providing further support for the use of 
this intelligence estimate.  
 GAI is hypothesized to be more resilient to the effects of neuropsychological insult than 
FSIQ. Tulsky et al. (2001) report “GAI serves as a better 'hold measure' because the subtests in 
this index show less of an age-associated decline in performance and seem less susceptible to 
being lowered by neuropsychological impairment” (p. 567). Data provided for the clinical 
sample in WAIS-III/WMS-III Technical Manual (The Psychological Corporation, 1997) indicate 
mean VCI and POI scores are greater than WMI and PSI scores, respectively, across groups of 
Alzheimer's disease, Huntington's disease, Parkinson's disease, traumatic brain injury, 
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schizophrenia, ADHD, math learning disorder, and reading disorder. This suggests VCI and POI 
may be less vulnerable to the effects of brain injury than WMI and PSI. Furthermore, Hawkins 
(1998) analyzed the WAIS-III/WMS-III clinical sample data and concluded PSI appears to be 
particularly sensitive to brain dysfunction, as it was the lowest score for all clinical groups. VCI 
was also found to be the highest score in the majority of groups, underscoring the relative 
stability of this index. Again, this data supports the use of GAI over FSIQ when attempting to 
measure intellectual ability in clinical groups.  
 With the development of WAIS-III GAI normative tables, many researchers sought to 
compare GAI and FSIQ in various clinical groups. If GAI is a more stable estimate of general 
ability, as the creators argue, then it is expected to be a better “anchor point” from which to 
measure cognitive strengths and weaknesses. Harrison, DeLisle, and Parker (2007) examined the 
relationship of GAI and FSIQ in a diagnostically mixed sample of patients with neurocognitive 
and psychiatric disorders noting: 
 It is precisely among groups with suspected or known neurological injury or dysfunction 
 that the use of  FSIQ scores as a general estimate of intelligence has been most questioned 
 in recent years. In these cases, FSIQ scores are likely to be lower when PSI and WMI 
 subtests are included then when they are not, because PSI and WMI tend to be 
 substantially impaired in neurologically compromised clients. (p.248) 
 Participants in this study were 381 college students assessed at a university-based 
assessment center. Diagnoses were as follows: 66.4% neurocognitive disorder, 13.9% psychiatric 
disorder, and 19.7% without axis I diagnosis. Although the correlation between GAI and FSIQ 
for all participants was .95, there was a statistically significant GAI-FSIQ difference of 3.39 for 
the neurocognitive group, while the GAI-FSIQ differences of 1.04 for the psychiatric and .95 for 
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the no diagnosis groups were nonsignificant. The authors conclude this data supports contentions 
of other researchers (Dumont & Willis, 2001a, 2001b; Prifitera et al., 1998) that GAI and FSIQ 
differ in individuals with neuropsychological impairment; thus the GAI may provide a useful 
estimate of general cognitive functioning in cases in which there are potential impairments in 
processing speed and/or working memory. In a similar study, Iverson, Lange, Viljoen, and Brink 
(2006) found the mean GAI score was 5.3 and 4.2 points higher than average FSIQ scores in 
neuropsychiatry and forensic psychiatry inpatient samples, respectively. They conclude this 
supports the assertion that GAI is more resilient to the effects of compromised brain function in 
comparison to the traditional FSIQ composite score.  
 Several authors have examined the utility of GAI in discrepancy analysis (Lange, 
Chelune, & Tulsky, 2006; Lange & Chelune, 2006; Glass, Bartel, & Ryan, 2009). Lange et al. 
(2006) analyzed the relationship between the GAI and WMS-III Memory Indices using the 
WAIS-III/WMS-III standardization sample and developed GAI-memory discrepancy base rate 
data (Lange et al., 2006, p. 392). The authors note that large differences between GAI and 
memory scores are not uncommon in high ability, but become significant at lower levels due to 
the fact these discrepancies are relatively uncommon. This indicates the relationship between 
GAI and memory is more linear at lower levels of intelligence, but becomes disparate at higher 
levels, an argument that supports Dodrill’s (1997) position.  
 Lange and Chelune (2006) further assessed the utility of GAI-WMS-III Index 
discrepancy scores for evaluating memory impairment. These authors utilized the base rate tables 
provided in Lange et al. (2006) to compare discrepancy scores for patients with Alzheimer’s 
disease and healthy participants. Discrepancy scores were computed using the simple difference 
method (i.e., GAI score minus memory score), both stratified by GAI ability level and 
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unstratified. A predicted difference method was also used (i.e., IQ predicted memory score 
minus obtained memory score). Results indicated no difference in GAI-WMS-III Index 
discrepancy scores within each group using the simple difference and predicted difference 
methods, thus supporting the use of either of these methods for GAI discrepancy analysis. 
Examining performance between groups revealed the Alzheimer's patients had larger GAI-
memory discrepancy scores than the normal group, leading the authors to conclude all GAI-
WMS III Index discrepancy scores “consistently demonstrated high sensitivity, specificity, and 
predictive power values for differentiating patients with Alzheimer’s type dementia versus 
healthy participants” (p. 600). However, in this study there was no clear evidence the GAI-
memory discrepancy scores provided any additional interpretive information than the WMS-III 
index scores alone; thus, standardized scores alone may provide adequate information to 
distinguish impaired memory from normal performance. 
 Glass et al. (2009) compared GAI-WMS-III with FSIQ-WMS-III discrepancies in a 
sample of patients with substance abuse disorders referred for neuropsychological evaluation due 
to memory complaints. Again, GAI and FSIQ were highly correlated (r = .96) and resulted in 
similar mean scores. Across comparisons, the GAI-memory discrepancy scores were greater than 
the FSIQ-memory discrepancies, though the difference was only 1.5 points. The practical 
significance of these differences was small as measured by Cohen’s d, (approximately .12). The 
authors concluded that although GAI does appear less sensitive to compromised brain function, it 
does not necessarily provide any additional information compared to FSIQ in IQ-memory 
discrepancy analysis.  
 In summary, one of the methods of determining whether memory test performance 
represents impairment is comparing it to a baseline of previous functioning in discrepancy 
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analysis. While IQ scores have traditionally been used as the baseline measure, more recently 
GAI has been proposed as an alternative estimate of general mental ability that may be a more 
stable measure in the context of brain dysfunction. The utility of GAI in discrepancy analysis has 
yet to be established, as the few studies examining its use suggest it may not provide additional 
information relative to FSIQ discrepancy scores, or even memory scores alone. Further, there are 
differing positions in the literature regarding the relationship between intelligence and memory, 
for both FSIQ and GAI. The literature tends to support a strong relationship between intelligence 
and memory when intelligence is below average but this relationship decreases for average and 
above intelligence. The utility of discrepancy analysis as a method of measuring memory decline 
is unclear until there is a better understanding of the relationship between intelligence and 
memory.    
Limitations of Previous Research 
 The research reviewed above appears to have limitations in three primary areas:  
1. Most previous studies of discrepancy analysis have used FSIQ as the baseline 
intelligence score. While it has been suggested GAI is a more stable measure of 
intelligence, thus better for discrepancy analysis, there is limited research utilizing the 
GAI for this purpose. 
2. Existing research in discrepancy analysis has exclusively used composite memory 
indexes. However, because it is not always practical or desirable to administer all the 
tests necessary to obtain an index score, it would be useful to know the relationship of 
FSIQ and GAI with individual memory tests. 
3. It may be that more specific measures of baseline cognitive ability are more 
predictive of memory test performance than global measures. For example, the VCI 
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and POI may be more strongly associated with performance on verbal and 
visuographic memory tests, respectively, than the FSIQ and GAI. To date, there is no 
research on this.  
Purpose of the Study   
The purposes of the present study were to: 
1. Compare FSIQ and GAI scores, and compare the relationship of each to memory test 
scores.  
2. Compare FSIQ and GAI scores to performance on individual tests of verbal and 
visuographic memory 
3. Compare VCI and POI with performance on verbal and visuographic memory tests, 
respectively. 
  
Method 
Sample 
 Participants were 167 patients referred to a university doctoral clinical psychology 
training and research center for neuropsychological evaluation.  Eighty-eight were female and 79 
were male ranging in age from 18 to 62 years (mean age = 29.76, SD = 10.84). The sample 
averaged 13.83 years of education (SD = 2.32). The majority of the patients were Caucasian 
(84.4%) and the next largest group represented was Latino/Hispanic American (3.6%). Based on 
cognitive evaluation primary Axis I diagnoses were ADHD (24.6%), Reading Disorder (14.4%), 
Learning Disorder NOS (13.2%), and Cognitive Disorder NOS (9.6%; See Table 1).  
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Table 1 
Demographic characteristics of sample (N=167) ______________________________________ 
Characteristic                               Frequency               %___________________________ 
Age    
18-19     31  18.5 
 20-29     71  42.5 
 30-39     31  18.5 
 40-49     23  13.8 
 50-59     10    6.0 
 60+       1    0.6 
  
Education      
Less than 12    14    8.4  
 High School Graduate  27  16.2 
 Some College    81  48.5 
 College Graduate   17  10.2 
 Education Beyond College  16    9.6 
 Not Reported    10    6.0 
 
Ethnicity 
 Caucasian             141  84.4 
 Latino/Hispanic American    6    3.6 
 African American     5    3.0 
 Asian American     5    3.0 
 Native American     1    0.6 
 Other (including multiethnic)    7    4.2 
 Not Reported      2    1.2 
  
Primary Axis I Diagnosis 
 ADHD     41  24.6 
 Reading Disorder   24  14.4 
 Learning Disorder, NOS  22  13.2 
 Cognitive Disorder NOS  16    9.6 
 Anxiety Disorder   13    7.8 
 Math Disorder    10    6.0 
 Mood/Depressive Disorder  10    6.0 
 No Diagnosis    10    6.0   
 Asperger’s Syndrome     7    4.2 
 Adjustment Disorder     5    3.0 
 Disorder of Written Expression   3    1.8 
 Substance Disorder     3    1.8 
 Expressive Language Disorder   1    0.6 
 Psychotic Disorder     1    0.6 
 Miscellaneous V-codes    1    0.6 
______________________________________________________________________________ 
 
 
 
25 
Measures 
 
 Neuropsychological evaluation included the WAIS-III, Rey-Osterrieth Complex Figure 
Test (RCFT; Meyers & Meyers, 1996), California Verbal Learning Test – Second Edition 
(CVLT-II; Delis, Kaplan, Kramer, & Ober, 2000), Logical Memory (LM) subtest of the WMS-
III and Visual Reproduction (VR) subtest of the WMS-III (Wechsler, 1997b).  Tests used as 
measures of cognitive and memory domains are listed in Table 2.  
 
Table 2 
Measures______________________________________________________________________ 
Construct                                                 Measure______________________________________         
Global Intellectual Ability      WAIS-III Full Scale IQ (FSIQ) 
         WAIS-III General Ability Index (GAI) 
 
General Verbal Ability      WAIS-III Verbal Comprehension Index (VCI) 
 
General Visuospatial Ability      WAIS-III Perceptual Organization Index (POI) 
 
Verbal Memory        WMS-III Logical Memory II- Delayed Recall  
          CVLT-II Long Delay Free Recall  
 
Visuospatial Memory        WMS-III Visual Reproduction II- Delayed Recall  
          RCFT Delayed Recall Trial  
______________________________________________________________________________ 
 
Procedures  
 Informed consent was obtained from all participants at the time of evaluation. 
Neuropsychological tests were administered and scored by trained graduate students according to 
the standardized procedures outlined in the respective manuals. The GAI was calculated 
following the procedure outlined in Tulsky et al. (2001) by summing the scaled scores for Matrix 
Reasoning, Block Design, Vocabulary, Similarities, Information, and Picture Completion and 
deriving the GAI from the conversion table presented in Tulsky et al.’s (2001) article. For FSIQ, 
GAI, VCI, and POI scores subjects were grouped into below average (< 89), average (90-109), 
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and above average (> 110) groups (See Table 3). Diagnoses were grouped into three categories: 
ADHD; Learning (LD) and Cognitive Disorders; and Other. The diagnostic composition of each 
intelligence/ability estimate in presented in Tables 4 - 7. Results of chi-squared analyses revealed 
the proportion of patients different diagnoses was not significantly different by ability level for 
FSIQ (χ² = 1.76, p = .779), GAI (χ² = 1.12, p = .891), VCI (χ² = 2.29, p = .683), or POI (χ² = .41, 
p = .981).   
 
Table 3 
Means and standard deviations for intelligence estimates stratified by ability level_____________ 
    N  %  M  SD_______________ 
FSIQ 
 BA   19  11.4  84.16  4.65 
 A   93  55.7            101.13  4.88  
 AA   55  32.9            120.09  8.46 
 
GAI 
 BA   15    9.0   85.73  2.55 
 A   76              45.5             101.74  4.88 
 AA   76   45.5             122.14            10.74 
 
VCI 
 BA   13    7.8   82.69  6.58 
 A   87  52.1            100.02  5.23 
 AA   67  40.1            122.57  9.42 
 
POI 
 BA   15    9.0              82.13  5.14 
 A   79  47.3            102.16  5.05 
 AA   73  43.7            123.10  8.78 
______________________________________________________________________________ 
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Table 4 
Chi Square Results for FSIQ and diagnostic groups*___________________________________ 
__________________   N    %_____________________ 
Below Average    19 
 LD/Cognitive Disorder  12   63.1   
 ADHD     3   15.8   
 Other     4   21.1   
 
Average     93 
 LD/Cognitive Disorder  45   48.8   
 ADHD     23   24.7   
 Other     25   26.9   
 
Above Average    55 
 LD/Cognitive Disorder  26   47.2   
 ADHD     15   27.3   
 Other     14   25.5   
______________________________________________________________________________ 
*χ² = 1.76, p = .779 
 
 
 
 
Table 5 
Chi Square Results for GAI and diagnostic groups*____________________________________ 
__________________   N    %_____________________ 
 
Below Average    15 
 LD/Cognitive Disorder  9   60.0 
 ADHD     3   20.0 
 Other     3   20.0 
 
Average     76 
 LD/Cognitive Disorder  39   51.3 
 ADHD     18   23.7 
 Other     19   25.0 
 
Above Average    76 
 LD/Cognitive Disorder  35   46.1 
 ADHD     20   26.3 
 Other     21   27.6 
______________________________________________________________________________ 
* χ² = 1.12, p = .891 
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Table 6  
Chi Square Results for VCI and diagnostic groups* ____________________________________ 
__________________   N               %_____________________ 
 
Below Average    13 
 LD/Cognitive Disorder  9   69.2 
 ADHD     2   15.4 
 Other     2   15.4 
 
Average     87 
 LD/Cognitive Disorder  41   47.1 
 ADHD     23   26.4 
 Other     23   26.4 
 
Above Average    67 
 LD/Cognitive Disorder  33   49.3 
 ADHD     16   23.9 
 Other     18   26.9 
______________________________________________________________________________ 
* χ² = 2.29, p = .683 
 
 
 
 
Table 7 
Chi Square Results for POI and diagnostic groups* ____________________________________ 
__________________   N    %_____________________ 
 
Below Average    15 
 LD/Cognitive Disorder  8   53.3 
 ADHD     3   20.0 
 Other     4   26.7 
 
Average     79 
 LD/Cognitive Disorder  40   50.6 
 ADHD     20   25.3 
 Other     19   24.1 
 
Above Average    73 
 LD/Cognitive Disorder  35   47.9 
 ADHD     18   24.7 
 Other     19   26.0 
______________________________________________________________________________ 
* χ² = .41, p = .981   
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Results 
 Using the Bonferroni approach to control for Type I errors, Pearson product-moment 
correlations between the independent variables (FSIQ, GAI, VCI, and POI) and the dependent 
variables (Delayed trials of the CVLT, LM, VR, and RCFT) required a p value of less than .002 
(.05/28) for significance. The correlation coefficients presented in Table 8 support the hypothesis 
the IQ measures are positively correlated with the memory measures and reach statistical 
significance. In addition, it is also apparent the FSIQ and GAI are significantly correlated (r = 
.92, p < .001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 8 
Two-tailed Pearson correlation coefficients for  FSIQ, GAI, VCI, POI, LM, CVLT, VR and RCFT _______________________________ 
Measure FSIQ  GAI  VCI  POI  LM  CVLT  VR  RCFT _____ 
FSIQ  1  .92**  .81**  .76**  .40**  .34**  .35**  .40**   
GAI  --  1  .87**  .82**  .36**  .28**  .37**  .42**   
VCI  --  --  1  .45**  .43**  .29**  .26**  .30** 
POI  --  --  --  1  .17*  .19*  .38**  .45** 
LM  --  --  --  --  1  .42**  .37**  .22** 
CVLT  --  --  --  --  --  1  .50**  .32** 
VR  --  --  --  --  --  --  1  .48** 
RCFT  --  --  --  --  --  --  --  1 
 
*p < .05 
**p < .006 
 
 
 
Paired sample t-tests indicated the mean GAI score (M = 109.59, SD = 14.67) was significantly 
higher than the mean FSIQ score [M = 105.44, SD =13.12; t (166) = -9.44, p < .001], by 4.14 
points. The magnitude of difference between the means, as measured by the Cohen’s d statistic (-
0.30), was a small effect size. 
 One-way between-groups MANOVA was performed to investigate differences in 
memory scores at various FSIQ levels. The four memory measures were the dependent variables 
and stratified IQ ability (below average, average, and above average) was the independent 
variable. Preliminary assumption testing was conducted to check for normality, linearity, 
univariate and multivariate outliers, and homogeneity of variance-covariance matrices, with no 
serious violations noted. MANOVA results revealed significant differences among the FSIQ 
categories on the dependent variables: F (8, 322) = 6.07, p < .001; Wilks’ Lambda = .76; partial 
eta squared = .13. One-way ANOVA revealed significant differences between FSIQ groups for 
LM [F (2, 164) = 12.93, p < .001, partial eta squared = .14], CVLT [F (2, 164) = 9.11, p < .001, 
partial eta squared = .10], VR [F (2, 164) = 12.91, p < .001, partial eta squared = .14], and RCFT 
[F (2, 164) = 12.47, p < .001, partial eta squared = .13]. Scheffe post hoc analyses revealed that 
memory scores were significantly different for all FSIQ groups on LM, VR, and RCFT.  The 
below average FSIQ group scored significantly lower than the average and above average groups 
and the average FSIQ group’s memory scores were significantly lower than the above average 
group. On the CVLT, the above average FSIQ group had a significantly higher score than the 
average and below average groups. The difference between the below average and average 
groups was not significant for CVLT. Table 9 presents means and standard deviations for each 
memory test at each FSIQ level. Table 10 presents the differences in memory scores by FSIQ 
level and shows medium to large effect sizes for significant differences.  
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Table 9 
Means and standard deviations for memory tests stratified by FSIQ level*____________________ 
   FSIQ       M    SD    ______ 
 
LM   Below Average    91.47  19.57 
      Average  102.37  12.50 
   Above Average 110.13  15.04   
CVLT   Below Average   88.11  20.51 
   Average    97.38  14.96 
   Above Average 105.24  15.87 
 
VR   Below Average   94.68  21.51 
   Average  109.42  15.61 
   Above Average 117.22  17.14 
 
RCFT   Below Average   71.89  17.48 
   Average    88.30  18.18 
   Above Average   96.51  19.88  ______________________________________________________________________________ 
*Values are standard scores with Mean of 100 and Standard Deviation of 15 
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Table 10 
Scheffe analyses for memory scores by FSIQ level with effect sizes________________________ 
  Comparison       Mean Difference        95% CI                 p         Cohen’s d__ 
 
LM  BA-A    10.89                    2.01 – 19.78            .012            .66 
  A-AA      7.76                    1.76 – 13.77            .007            .56  
    BA-AA   18.65                    9.26 – 28.05            .000             1.07 
 
CVLT  BA-A      9.27                      .65 – 19.19            .073   
  A-AA      7.86                    1.16 – 14.56            .017   .51 
  BA-AA   17.13                   6.64 – 27.62            .000            0.93  
 
VR  BA-A    14.74        4.25 – 25.22       .003   .78 
  A-AA      7.80          .71 – 14.88       .027   .48 
  BA-AA   22.53      11.45 – 33.62       .000            1.16  
 
RCFT  BA-A    16.41        4.79 – 28.03            .003   .92 
  A-AA     8.21          .36 – 16.06            .038   .43  
  BA-AA  24.61      12.33 – 36.90            .000            1.32 
______________________________________________________________________________ 
BA (Below Average), A (Average), AA (Above Average) 
 
 
A one-way between-groups MANOVA was performed to investigate differences in 
memory scores by stratified GAI levels using the four memory measures as dependent variables. 
There was no violation in preliminary assumption testing. MANOVA results revealed significant 
differences among the GAI categories on the dependent variables: F (8, 322) = 4.71, p < .001; 
Wilks’ Lambda = .80; partial eta squared = .11. One-way ANOVA results revealed GAI category 
differences were significant for LM [F (2, 164) = 6.94, p = .001, partial eta squared = .08], 
CVLT [F (2, 164) = 5.14, p = .007, partial eta squared = .06], VR [F (2, 164) = 10.61, p < .001, 
partial eta squared = .12], and RCFT [F (2, 164) = 13.06, p < .001, partial eta squared = .14]. 
Scheffe post hoc analyses revealed that memory scores were significantly different for all GAI 
group comparisons on VR and RCFT with higher GAI associated with higher memory scores. 
On the CVLT and LM tests, the below average group’s scores were significantly lower than the 
above average group.  The differences between the below average-average and average-above 
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average groups were not significant. Table 11 presents memory test means and standard 
deviations for the GAI groups. Table 12 presents the differences in memory scores by GAI level 
and shows medium to large effect sizes for significant differences. 
 
Table 11 
Means and standard deviations for memory tests stratified by GAI level*_____________________ 
   GAI       M    SD    ______ 
 
LM   Below Average    92.20  17.49 
      Average  102.45  14.28 
   Above Average 107.18  14.68   
CVLT   Below Average   90.07  19.98 
   Average    96.70  15.21 
   Above Average 102.87  16.62 
 
VR   Below Average   94.80  17.83 
   Average  108.03  16.41 
   Above Average 115.66  17.57 
 
RCFT   Below Average   69.00  16.51 
   Average    87.17  17.19 
   Above Average   95.08  20.31 
______________________________________________________________________________
*Values are standard scores with Mean of 100 and Standard Deviation of 15 
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Table 12 
Sheffe analyses for memory scores by GAI level with effect sizes________________________ 
  Comparison       Mean Difference        95% CI                 p         Cohen’s d__ 
LM  BA-A    10.25                    .06 – 20.55            .052    
  A-AA      4.74                  1.18 – 10.65            .145 
  BA-AA  14.98                   4.68 – 25.29            .002              0.93  
   
CVLT  BA-A      6.63                  4.76 – 18.02            .358   
  A-AA      6.17                    .37 – 12.71    .069    
  BA-AA   12.80      1.41 – 24.19             .023               0.70 
  
VR  BA-A    13.23      1.31 – 25.14 .025   .77 
  A-AA      7.63        .79 – 14.47 .024   .45 
  BA-AA  20.86                   8.95 – 32.77            .000                1.18 
 
RCFT  BA-A    18.17      5.17 – 31.17  .003            1.08 
  A-AA      7.91                   .44 – 15.37   .035   .42 
  BA-AA   26.08                13.08 – 39.08   .000               1.41 
______________________________________________________________________________ 
BA (Below Average), A (Average), AA (Above Average) 
 
 A one-way between-groups MANOVA was performed to investigate differences in 
verbal memory scores at various VCI levels. There was no violation in preliminary assumption 
testing. MANOVA results revealed significant differences among the VCI categories on the 
dependent variables: F (4, 326) = 3.72, p = .006; Wilks’ Lambda = .92; partial eta squared = 
.044. One-way analysis of variance revealed VCI group differences were significant for LM [F 
(2, 164) = 7.14, p = .001, partial eta squared = .08], but not for CVLT [F (2, 164) = 1.39, p = 
.251, partial eta squared = .02]. Scheffe post hoc analysis revealed that the above average VCI 
group’s LM scores were significantly higher than the other two groups. The difference between 
the below average and average groups’ LM was not significant. Table 13 presents means and 
standard deviations for verbal memory tests at each VCI level. Table 14 presents the differences 
in verbal memory scores by VCI level and shows medium to large effect sizes for significant 
differences.  
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Table 13 
Means and standard deviations for verbal memory tests stratified by VCI level*_______________ 
   VCI       M    SD    _____ 
 
LM   Below Average    92.54  14.36 
      Average  102.02  14.32 
   Above Average 108.00  15.35   
CVLT   Below Average   96.77  16.32 
   Average    97.21  15.52 
   Above Average           101.54  18.14 
______________________________________________________________________________ 
*Values are standard scores with Mean of 100 and Standard Deviation of 15 
 
 
Table 14 
Scheffe analyses for verbal memory scores by VCI level with effect sizes____________________ 
  Comparison       Mean Difference        95% CI                 p         Cohen’s d__ 
LM  BA-A      9.48                   1.35 – 20.32              .100   
  A-AA      5.98                     .06 – 11.90              .047                .40  
  BA-AA   15.46                   4.42 – 26.50              .003               1.04 
     
CVLT  BA-A      0.44                 11.81 – 12.69              .996   
  A-AA      4.33                  2.37 – 11.03    .282  
  BA-AA     4.77                  7.72 – 17.25              .642  
______________________________________________________________________________ 
BA (Below Average), A (Average), AA (Above Average) 
 
 The final one-way between-groups MANOVA performed investigated differences in 
visuospatial memory scores at various POI levels. Preliminary assumption testing was not 
violated. MANOVA results revealed significant differences among the POI groups on the 
dependent variables: F (4, 326) = 12.84, p < .001; Wilks’ Lambda = .75; partial eta squared = 
.133. One-way analysis of variance revealed POI group differences were significant for VR [F 
(2, 164) = 16.74, p < .001, partial eta squared = .17] and RCFT [F (2, 164) = 19.12, p < .001, 
partial eta squared = .19]. Scheffe post hoc analyses revealed that VR scores were significantly 
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different for all group comparisons with higher POI associated with higher memory scores. The 
above average POI group scored significantly higher on RCFT than the other two groups. RCFT 
scores for the below average and average groups were not significantly different. Table 15 
presents means and standard deviations for visuospatial memory tests at each POI level. Table 16 
presents the differences in visuospatial memory scores by POI level and shows effect sizes were 
medium to large for significant differences. 
 
Table 15 
Means and standard deviations for visuospatial memory tests stratified by POI level*__________ 
   POI       M    SD    _____ 
 
VR   Below Average   92.80  16.53 
   Average  107.05  15.77 
   Above Average 117.44  17.31 
 
RCFT   Below Average   74.40  19.10 
   Average    83.24  16.35 
   Above Average   98.55  19.56 
______________________________________________________________________________ 
*Values are standard scores with Mean of 100 and Standard Deviation of 15 
 
 
Table 16 
Scheffe analyses for visuospatial memory scores by POI level with effect sizes_______________ 
  Comparison       Mean Difference        95% CI                 p         Cohen’s d__ 
VR  BA-A    14.25     2.75 – 25.75             .010   .88 
  A-AA    10.39     3.76 – 17.02             .001   .63 
  BA-AA   24.64   13.06 – 36.21   .000            1.46 
 
RCFT  BA-A      8.84     3.72 – 21.04             .224    
  A-AA    15.31     8.07 – 22.55             .000   .85 
  BA-AA   24.15   11.50 – 36.79             .000                1.25 
______________________________________________________________________________ 
BA (Below Average), A (Average), AA (Above Average) 
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Discussion 
In discrepancy analysis a score that represents a patient’s overall level of cognitive 
ability, or intelligence, is compared to their score on a neuropsychological test, such as a memory 
measure. If the memory score is significantly below the intelligence score, this score discrepancy 
is taken as indication of a memory deficit. In order to be able to reliably identify when score 
discrepancies are significant, the normal relationship between intelligence and other 
neuropsychological test scores must be established. The primary purpose of this study was to 
examine the relationship between intelligence scores and memory test scores. Some researchers 
contend that using GAI in discrepancy analysis provides a more stable measure of premorbid 
intelligence than FSIQ because GAI omits measures of working memory that are less correlated 
with an overall intelligence factor and are more vulnerable to the effects of brain injury. A 
second purpose of this study was to compare the relationship of GAI and FSIQ to each other and 
of each index to memory test scores. Finally, a topic not addressed in the literature is the 
relationship of specific measures of overall verbal and visuospatial ability to verbal and 
visuographic memory tests respectively. If more specific measures of overall cognitive 
functioning, such as VCI and POI, are more strongly correlated with specific types of memory 
test performance, they may be superior to FSIQ and GAI for discrepancy analysis. The third 
purpose of this study was to examine the relationship of more specific measures of overall 
cognitive functioning, VCI and POI, to verbal and visuographic memory test scores. 
The relationship between the global intelligence estimates will be discussed first. GAI 
and FSIQ were strongly correlated (r = .92) and mean GAI was significantly higher than mean 
FSIQ by 4 points. This is consistent with previous literature (Prifitera et al., 1998; Dumont & 
Willis, 2001a, 2001b; Harrison et al., 2007) and appears to represent the decreased vulnerability 
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of GAI to neurological damage (Tulsky et al., 2001). Previous studies have shown that GAI is 
about 4 points higher than FSIQ in groups of patients with neuropathological conditions.  
Although the patients in this study did not have neuropathological conditions, it appears subtests 
included in the FSIQ were susceptible to the developmental cognitive and psychological 
disorders they had. The higher GAI scores suggest subtests composing this intelligence estimate 
are less susceptible to these conditions and thus, may be preferable in discrepancy analysis for 
these patients.  However, the small absolute difference in the groups’ GAI and FSIQ – four 
points – means that for most patients using FSIQ or GAI in discrepancy analysis would produce 
the same clinical result.  Only for those few patients for which the FSIQ – memory test 
discrepancy analysis was of marginal significance would the higher GAI result in a more 
clinically significant discrepancy that may lead to a different clinical decision.  Follow up 
research of base rates would clarify how often this occurs in clinical groups.  
Mean memory test scores for the below average, average and above average FSIQ groups 
were within 3 points of their GAI counterparts, indicating there is not a clinically significant 
difference in the two approaches with regard to level of memory performance. Further, the 
differences in memory test scores between FSIQ ability levels (i.e., below average-average; 
average-above average; below average-above average) were within 5 points of comparable GAI 
group comparisons. Despite similarities in the magnitude of intelligence-memory difference for 
FSIQ and GAI, between ability group differences for verbal memory tests were significant only 
for FSIQ and not for GAI.  This may indicate the subtests in the Processing Speed and Working 
Memory Indexes are associated with increased variance in verbal memory test performance, thus 
resulting in statistical significance for FSIQ but not GAI groups despite nearly identical mean 
differences. Visuographic memory differences for the groups were significant for both FSIQ and 
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GAI.  Despite statistical results, these findings indicate that clinically, in this population, using 
FSIQ and GAI produces very similar estimates of overall intelligence and the magnitude of 
difference between below average, average, and above average groups’ memory scores is 
comparable with either FSIQ or GAI. Again, follow up research of base rates would clarify how 
often there are exceptions to this comparability.  
 Next, the relationship between intelligence scores and memory test scores is considered. 
Using either FSIQ or GAI, there are differences in memory test performance related to level of 
intelligence. As intelligence scores increase, memory scores do as well. In general, the 
magnitude of memory test score difference was greater between the below average and average 
groups (7-18 points) than between the average and above average groups (4-8 points). In 
addition, there was a trend for memory scores to exceed intelligence in the below average groups 
while intelligence exceeded memory in the above average groups. This is consistent with the 
position that intelligence and memory are not linear correlates, supported by Dodrill (1997), 
Williams (1997), Hawkins (1998), Larabee (2000), and Hawkins and Tulsky (2001). 
Nonetheless, there is a clear and consistent trend on all memory tests of higher performance with 
higher intelligence. Overall, this data appears to support Dodrill's (1999) contention of the myth: 
"Just as below average performances on neuropsychological tests are found when intelligence is 
below average, to that same degree above-average performances on neuropsychological tests are 
expected when intellectual abilities are above average" (p.568). These findings indicate that 
although memory scores increase with intelligence, they do not increase at the same rate between 
the below average and above average intelligence ranges.  
 Thus, when using discrepancy analysis to assess a patient for memory deficits, it is 
apparent that intelligence level must be taken into account. The increase in memory scores from 
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below average to average intelligence generally was more than twice the increase from average 
to above average intelligence. This means we should not necessarily expect memory to be within 
the same range as intelligence in individuals with above average intelligence. This is clinically 
significant because if a neuropsychologist is not aware of this relationship, there is potential for 
false positive findings of memory decline using discrepancy analysis. Conversely, because 
memory scores tend to be greater than intelligence among below average intelligence groups 
small differences may represent a decline and the amount of discrepancy may need to be 
adjusted to reduce the possibility of false negative findings.  
   Given that verbal abilities tend to be more highly correlated with other verbal abilities 
than nonverbal abilities, it was hypothesized a global measure of verbal ability would be more 
strongly associated with verbal memory than global measures that include both verbal and 
nonverbal abilities (i.e., FSIQ and GAI). Similarly, global measures of visuospatial ability may 
be more strongly related to visuographic memory than FSIQ or GAI.  Results of this study reveal 
there were statistically significant correlations among the VCI, POI, and memory measures. VCI 
had a moderate correlation with LM (r = .43) and a low correlation with the CVLT (r = .29).  
The correlation between the VCI and nonverbal memory measures was low to moderate (VR: r 
= .26; RCFT: r = .30) and comparable to CVLT. The POI had moderate correlations with the 
nonverbal memory measures (VR: r = .38; RCFT: r = .45) and low correlations with the verbal 
memory measures (LM: r = .17; CVLT: r = .19). Although correlations between global verbal 
and visuospatial indexes and respective memory tests were statistically significant, they were not 
particularly strong.  
 Examination of verbal memory test scores across the VCI, GAI, and FSIQ reveal nearly 
identical scores for Logical Memory for below average, average, and above average groups. This 
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indicates there likely is not a clinically significant difference when using VCI, GAI, or FSIQ in 
discrepancy analysis with this measure. In contrast, there was very little difference in the CVLT 
scores of below average, average, and above average groups using the VCI, while there were 
more substantial differences in CVLT scores for the groups using FSIQ and GAI. It is possible 
that in addition to higher verbal abilities, the FSIQ and GAI groups also had higher cognitive 
abilities in other areas that allowed them to use a more effective strategy for organizing and 
encoding the more difficult material of the CVLT.  This is consistent with Rapport et al.'s (1997) 
findings that suggest other cognitive factors (e.g., problem solving, semantic organization) may 
overlap with intelligence and play an important role in memory tasks. 
 For visuographic memory measures, group means were within 5 points for POI, FSIQ, 
and GAI. Visual Reproduction scores were comparable for FSIQ, GAI, and POI, with the 
consistent finding of larger differences between below average-average mean scores than 
average-above average mean scores. This indicates there likely is not a clinically significant 
difference when using POI, GAI, or FSIQ in discrepancy analysis with VR. However, for the 
RCFT, the below average-average difference was twice as high for FSIQ and GAI than POI, 
indicating those with below average overall cognitive abilities performed quite poorly on this 
measure. Possibly those with low overall cognitive abilities (i.e. below average FSIQ and GAI) 
had little additional cognitive skill to compensate for visuospatial deficits and thus performed 
poorly on RCFT, while those who had only low visuospatial ability, as measured by POI, had 
higher cognitive abilities in other domains that allowed them to compensate for these deficits and 
perform better on this measure.  In contrast, the average – above average difference was twice as 
high for POI as it was for FSIQ and GAI.  Possibly just having high visuospatial ability was 
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sufficient to do better on the RCFT even though other cognitive abilities potentially were not at 
that level.  
Clinical Implications 
 For all intelligence estimates, the relationship between intelligence and memory test 
performance varied by test. Those with above average intelligence tended to have high average 
performance on LM and VR, but average performance on CVLT and RCFT. Below average 
intelligence groups generally had below average performance on CVLT and RCFT, with 
performance in the low end of the average range on LM and VR. This indicates that if 
discrepancy analysis is used comparing intelligence and memory, it will be necessary to have a 
different standard for what constitutes a significant discrepancy for different memory tests. 
 Another important consideration is that the below average groups tended to have memory 
test scores that were higher than intelligence estimates. This raises questions about the utility of 
discrepancy analysis for patients with below average intelligence. It is possible that less of a 
discrepancy is required with these patients, though it is difficult to determine what an appropriate 
amount would be until there is additional research on base rates. It is also possible that 
discrepancy analysis is altogether inappropriate for these individuals and it may be more useful 
to follow normative standards for identifying impairment. In this scenario a patient with below 
average intelligence and a below average memory score would be considered to have memory 
impairment, despite the fact there was not a substantial discrepancy between memory and IQ. 
The greater challenge for the patient with below average intelligence, however, is identifying 
memory decline.  Based on the present data, to conclude that a below average intelligence patient 
has memory decline (i.e. decline from premorbid level) the memory score would need to be 
lower than it would if using a normative comparison.  For example, a memory score at the 7th 
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percentile is 1.5 standard deviations below average and probably would be considered to 
represent memory decline for a patient with average intelligence.  This 7th percentile score is less 
than 1 standard deviation below the average memory score for a below average intelligence 
patient based on the present data.  For the below average intelligence patient, a score at the 2nd 
percentile is 1.5 standard deviations below average based on the present data and would be 
necessary to conclude memory decline for a below average intelligence patient.  Assessment of 
subjective and observed changes in memory remains a crucial part of the evaluation and may 
provide more insight into premorbid memory than intellectual estimates. 
Limitations and Directions for Future Studies 
 The limitations of this study may restrict how well results generalize to other populations. 
Given that a large proportion of the sample identified as Caucasian, it is not clear how well these 
results will apply to patients from the non-dominant culture. 
 Although the majority of the sample had diagnoses of ADHD or LD/Cognitive Disorder, 
results of this study are very similar to most of the existing research utilizing a normal sample, 
indicating those findings appear to also hold for ADHD and LD/Cognitive Disorder groups.  
 In addition, only 11% of the sample had IQ scores in the below average range. While this 
did not violate assumptions of equality, it may have reduced the power to detect significant 
differences for this group. 
 Another potential weakness is the use of the POI as an estimate of intelligence. While the 
creators of the GAI posit the POI is a useful measure of stable visuospatial ability, one must 
consider that several of the tests that comprise this index have time limitations. As a result, an 
individual who has processing speed deficits will be penalized, when in fact their visuospatial 
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abilities may be intact. Further research is needed with the POI without time limitations if this is 
to be used as a “hold” measure of visuospatial ability.  
 As others have posited, base rate data is needed to determine how frequently intelligence-
memory discrepancy scores occur at various intelligence levels. For example, a 14 point 
difference between intelligence and memory scores may be quite common in high average 
individuals, but rare among low average patients. Simple discrepancy analysis does not provide 
this information. 
Summary and Conclusions 
 Results of the current study indicate FSIQ and GAI produce very similar groups with 
below average, average and above average intelligence that have very comparable levels of 
memory performance.  Clinical decisions made using FSIQ and GAI in discrepancy analysis will 
be very similar in clinical populations that are comparable to the one used in this study.  Results 
from this study support previous findings that intelligence and memory are not linear correlates 
across all ability ranges. In this sample and in other studies, below average intelligence groups 
tend to have memory scores that exceed intelligence scores; the opposite pattern has been found 
in individuals with above average intelligence. Furthermore, there were larger memory score 
differences between below average and average groups than average and above average groups. 
If discrepancy analysis is used to detect memory impairment, it is essential to understand these 
patterns to reduce the risk of false positive or false negative clinical findings.  
 
 
 
 
 
 
46 
References 
Barona, A., Reynolds, C. R., & Chastain, R. (1984). A demographically based index of 
 premorbid intelligence for the WAIS-R. Journal of Consulting and Clinical Psychology, 
 52, 885-887. 
Bell, B. D. & Roper, B. L. (1998). “Myths of neuropsychology”: Another view. The
 Clinical Neuropsychologist, 12, 237-244. 
Blair, J. R. & Spreen, O. (1989). Predicting premorbid IQ: A revision of the National Adult 
 Reading Test. The Clinical Neuropsychologist, 3, 129-136. 
Bornstein, R. A., Chelune, G. J., & Prifitera, A. (1989). IQ – memory discrepancies in normal 
 and clinical samples. Psychological Assessment, 1, 203-206. 
Brooks, B. L., Strauss, E., Sherman, E. M. S., Iverson, G. L., & Slick, D. J. (2009). 
 Developments in neuropsychological assessment: Refining psychometric and clinical I
 nterpretive methods. Canadian Psychology, 50, 196-209. 
Crawford, J. R., Johnson, D. A., Mychalkiw, B., & Moore, J. W. (1997). WAIS-R performance 
 following closed-head injury: A comparison of the clinical utility of summary IQs, 
 factor scores, and subtest scatter indices. Clinical Neuropsychologist, 11, 345-355. 
Delis, D. C., Kaplan, E., Kramer, J. H., & Ober, J.A. (1987). California Verbal Learning Test: 
 Research Edition, Manual. San Antonio, TX: The Psychological Corporation. 
Delis, D. C., Kaplan, E., Kramer, J. H., & Ober, J.A. (2000). CVLT-II: California Verbal 
 Learning Test, Second Edition, Manual. New York, NY: The Psychological Corporation.  
Dodrill, C. B. (1978). Sex differences on the Halstead-Reitan Neuropsychological Battery and on 
 other neuropsychological measures. Journal of Clinical Psychology, 35, 236-241. 
Dodrill, C. B. (1997). Myths of neuropsychology. The Clinical Neuropsychology, 11, 1-17. 
 
 
47 
Dodrill, C. B. (1999). Myths of neuropsychology: Further considerations. The Clinical 
 Neuropsychologist, 13, 562-572. 
Feinberg, T. E. & Farah, M. J. (2003). Behavioral Neurology and Neuropsychology (2nd Edition). 
 New York, NY: McGraw-Hill. 
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state. Journal of 
 Psychiatric Research, 12, 189-198. 
Glass, L. A., Bartels, J. M., & Ryan, J. J. (2009). WAIS-III FSIQ and GAI in ability-memory 
 discrepancy analysis. Applied Neuropsychology, 16, 19-22. 
Halstead, W. C. (1947). Brain and Intelligence. Chicago: University of Chicago Press. 
Harrison, A. G., DeLisle, M. M., & Parker, K. H. C. (2007). An investigation of the General 
 Abilities Index in a group of diagnostically mixed patients. Journal of Psychoeducational 
 Assessment, 26, 247-259. 
Hawkins, K. A. (1998). Indicators of brain dysfunction derived from graphic representations of 
 the WAIS-III/WMS-III technical manual clinical samples data: A preliminary approach 
 to clinical utility. The Clinical Neuropsychologist, 12, 535-551. 
Hawkins, K. A. & Tulsky, D. S. (2001). The influence of IQ stratification on WAIS-III/WMS-III 
 FSIQ—General Memory Index discrepancy base-rates in the standardization sample. 
 Journal of the International Neuropsychological Society, 7, 875-880. 
Iverson, G. L., Lange, R. T., Viljoen, H., Brink, J. (2006). WAIS-III General Ability Index in 
 neuropsychiatry and forensic psychiatry inpatient samples. Archives of Clinical 
 Neuropsychology, 21, 77-82.  
Kaufman, A. S. & Lichtenberger, E. O. (1999). Essentials of WAIS-III Assessment. New Jersey:  
 John Wiley & Sons, Inc.  
 
 
48 
Lange, R. T. & Chelune, G. J. (2006). Application of new WAIS-III/WMS-III discrepancy 
 scores for evaluating memory functioning: Relationships between intellectual and 
 memory ability. Journal of Clinical and Experimental Neuropsychology, 28, 592-604. 
Lange, R. T., Chelune, G. J., & Tulsky, D. S. (2006). Development of WAIS-III General Ability 
 Index minus WMS-III memory discrepancy scores. The Clinical Neuropsychologist, 20, 
 382-395. 
Larrabee, G. J. (1987). Further cautions in interpretation of comparisons between WAIS-R and 
 Wechsler Memory Scale. Journal of Clinical and Experimental Neuropsychology, 9, 
 456-460. 
Larrabee, G. J. (2000). Association between IQ and neuropsychological test performance: 
 Commentary on Tremont, Hoffman, Scott, and Adams (1998). The Clinical 
 Neuropsychologist, 14, 139-145. 
Lezak, M. D., Howieson, D. B., & Loring, D. W. (2004). Neuropsychological Assessment –4th 
 Edition. New York: Oxford University Press. 
Matis, S. (1988). Dementia Rating Scale (DRS). Odessa, FL: Psychological Assessment 
 Resources. 
Meyers, J. E. & Meyers, K. R. (1995). Rey Complex Figure Test and Recognition Trial. Odessa, 
 FL: Psychological Assessment Resources. 
Mitrushina, M., Boone, K., & D’Elia, L. (1999). Handbook of Normative Data for 
 Neuropsychological Assessment. New York, NY: Oxford University Press. 
Moses, J. A., Pritchard, D. A., & Adams, R. L. (1997). Neuropsychological information in the 
 Wechsler Adult Intelligence Scale – Revised. Archives of Clinical Neuropsychology, 12, 
 97-109. 
 
 
49 
Prifitera, A. & Barley, W. D. (1985). Cautions in interpretation of comparisons between the 
 WAIS-R and the Wechsler Memory Scale. Journal of Consulting and Clinical 
 Psychology, 53, 564-565. 
Prifitera, A., Weiss, L. G., & Saklofske, D. H. (1998). The WISC-III in context. In A. Prifitera & 
 D. H. Saklofske (Eds.), WISC-III clinical use and interpretation: Scientist-practitioner 
 perspectives (p. 1 -38). San Diego, CA: Academic Press.  
Rapport, L. J., Axelrod, B. N., Theisen, M. E., Brines, D. B., Kalechstein, A. D., & Ricker, J. H. 
 (1997). Relationship of IQ to verbal learning and memory: Test and retest. Journal of 
 Clinical and Experimental Neuropsychology, 19, 655-666. 
Reitan, R. M. (1955c). Investigation of the validity of Halstead’s measures of biological 
 intelligence. Archives of Neurology and Psychiatry, 73, 28-35. 
Reitan, R. M. (1985). Relationships between measures of brain functions and general 
 intelligence. Journal of Clinical Psychology, 41, 245-253. 
Tariq, S. H., Tumosa, N., Chibnall, J. T., Perry, M. H., & Morley, J. E. (2006). Comparison of 
 the Saint Louis University mental status examination and the mini-mental state 
 examination for detecting dementia and mild neurocognitive disorder--a pilot study. The 
 American Journal of Geriatric Psychiatry, 14, 900-910. 
The Psychological Corporation. (1997). WAIS-III/WMS-III technical manual. San Antonio, TX: 
 The Psychological Corporation. 
The Psychological Corporation (2001a). WAIS-III/WMS-III/WIAT-II scoring assistant. San 
 Antonio,TX: The Psychological Corporation . 
 
 
50 
Tremont, G., Hoffman, R. G., Scott, J. G., & Adams, R. L. (1998). Effect of intellectual level on 
 neuropsychological test performance: A response to Dodrill (1997). The Clinical 
 Neuropsychologist, 12, 560-567. 
Tulsky, D. S., Saklofske, D. H., Wilkins, C., & Weiss, L. G. (2001). Development of a General 
 Ability Index for the Wechsler Adult Intelligence Scale – third edition. Psychological 
 Assessment, 13, 566-571. 
Vargha-Khadem, F. & Gadian, D. G. (1997). Differential effects of early hippocampal pathology 
 on episodic and semantic memory. Science, 227, 376-381. 
Waldmann, B. W., Dickson, A. L., Kazelskis, R. (1990). The relationship between 
 intellectual function and performance on the Wechsler Memory Scale. The Journal of 
 Genetic Psychology, 152, 57-69. 
Wechsler, D. (1945). Wechsler Memory Scale. New York: The Psychological Corporation. 
Wechsler, D. (1955). Manual for the Wechsler Adult Intelligence Scale. New York:  
The Psychological Corporation. 
Wechsler, D. (1981). Manual for the Wechsler Adult Intelligence Scale – Revised. 
 New York: The Psychological Corporation. 
Wechsler, D. (1987). Wechsler Memory Scale – Revised. San Antonio, TX: The Psychological 
 Corporation. 
Wechsler, D. (1997a). Wechsler Adult Intelligence Scale – Third Edition. San Antonio, TX: The 
 Psychological Corporation. 
Wechsler, D. (1997b). Wechsler Memory Scale – Third Edition.  San Antonio, TX: The 
 Psychological Corporation. 
Wechsler, D. (2008). Wechsler Adult Intelligence Scale – Fourth Edition. San Antonio, TX: The  
 
 
51 
 Psychological Corporation. 
Weiss, L. G., Saklofske, D. H., Prifitera, A., Chen, H. Y., & Hildebrand, D. K. (1999). The 
 calculation of the WISC-III General Ability Index using Canadian norms. Canadian 
 Journal of School Psychology, 14, 1-9.  
Wilding, J., Valentine, E., Marshall, P., & Cook, S. (1999). Memory, IQ, and examination 
 performance. Educational Psychology, 19, 117-131. 
Williams, J. M. (1992). The Memory Assessment Scales. Lutz, FL: Psychological 
 Assessment Resources. 
Williams, J. M. (1997). The prediction of premorbid memory ability. Archives of  
 Clinical Neuropsychology, 12, 745-756. 
 
 
 
 
 
